171 related articles for article (PubMed ID: 9192985)
21. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
[TBL] [Abstract][Full Text] [Related]
22. Serum tumour markers in lung cancer.
Hansen M
Scand J Clin Lab Invest Suppl; 1991; 206():93-101. PubMed ID: 1658919
[No Abstract] [Full Text] [Related]
23. [Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer].
Wei T; Luo RC; Zuo Q; Zhang JY; Miao JX; Lu HF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):858-9. PubMed ID: 16793621
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic and prognostic value of ProGRP in lung cancer.
Nisman B; Biran H; Ramu N; Heching N; Barak V; Peretz T
Anticancer Res; 2009 Nov; 29(11):4827-32. PubMed ID: 20032442
[TBL] [Abstract][Full Text] [Related]
25. How to express tumor markers in bronchoalveolar lavage.
Gómez de Terreros Caro FJ; Alvarez-Sala R; Prados MC; Callol L; Gómez de Terreros Sánchez FJ; Villamor J
Int J Biol Markers; 2004; 19(1):67-71. PubMed ID: 15077929
[TBL] [Abstract][Full Text] [Related]
26. Soluble Human Leukocyte Antigen-G in the Bronchoalveolar Lavage of Lung Cancer Patients.
Montilla D; Pérez M; Borges L; Bianchi G; Cova JA
Arch Bronconeumol; 2016 Aug; 52(8):420-4. PubMed ID: 27004472
[TBL] [Abstract][Full Text] [Related]
27. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase.
Giovanella L; Ceriani L; Bandera M; Garancini S
Int J Biol Markers; 2001; 16(1):50-5. PubMed ID: 11288956
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of hyaluronic acid values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma.
Hernández Hernández JR; García García JM; Martínez Muñíz MA; Allende Monclus MT; Ruibal Morell A
Int J Biol Markers; 1995; 10(3):149-55. PubMed ID: 8551057
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of carcinoembryonic antigen determination in bronchoalveolar lavage fluid. A comparative study among patients with peripheral lung cancer, pneumonia, and healthy individuals.
de Diego A; Compte L; Sanchis J; Enguidanos MJ; Marco V
Chest; 1991 Oct; 100(4):1060-3. PubMed ID: 1914558
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of interleukin-6 in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Dowlati A; Levitan N; Remick SC
J Lab Clin Med; 1999 Oct; 134(4):405-9. PubMed ID: 10521088
[TBL] [Abstract][Full Text] [Related]
31. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer.
Ahrendt SA; Chow JT; Xu LH; Yang SC; Eisenberger CF; Esteller M; Herman JG; Wu L; Decker PA; Jen J; Sidransky D
J Natl Cancer Inst; 1999 Feb; 91(4):332-9. PubMed ID: 10050866
[TBL] [Abstract][Full Text] [Related]
32. Correlation between matrix metalloproteinase 9 and 18F-2-fluoro-2-deoxyglucose-positron emission tomography as diagnostic markers of lung cancer.
Fiorelli A; Rizzo A; Messina G; Izzo A; Vicidomini G; Pannone G; Santini M; Di Domenico M
Eur J Cardiothorac Surg; 2012 Apr; 41(4):852-60. PubMed ID: 22219420
[TBL] [Abstract][Full Text] [Related]
33. Serum neurone-specific enolase and other neuroendocrine markers in lung cancer.
Ledermann JA
Eur J Cancer; 1994; 30A(5):574-6. PubMed ID: 8080666
[No Abstract] [Full Text] [Related]
34. [Detection and diagnostic value of serum carcinoembryonic antigen and cytokeratin 19 fragment in lung cancer patients].
Hang ZQ; Zheng MF; Huang JH
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):847-9. PubMed ID: 22335951
[TBL] [Abstract][Full Text] [Related]
35. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
36. Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema.
Löfdahl JM; Cederlund K; Nathell L; Eklund A; Sköld CM
Eur Respir J; 2005 Feb; 25(2):275-81. PubMed ID: 15684291
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of a multiple biomarker assay in patients with lung cancer. A study with logistic regression analysis.
Lombardi C; Tassi GF; Pizzocolo G; Donato F
Chest; 1990 Mar; 97(3):639-44. PubMed ID: 1689630
[TBL] [Abstract][Full Text] [Related]
38. Temperature and serum proinflammatory cytokine changes in patients with NSCLC after BAL.
Georgiades G; Myrianthefs P; Venetsanou K; Kythreoti A; Kyroudi A; Kittas C; Baltopoulos G
Lung; 2003; 181(1):35-47. PubMed ID: 12879338
[TBL] [Abstract][Full Text] [Related]
39. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma].
Lorenz J; Gillmann-Blum D; Jensen M; Kreienberg R
Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and prognostic significance of tumor markers cytokeratin 19 fragment, carcinoembryonic antigen, and neuron-specific enolase in lung cancer].
Zemaitis M; Sakalauskas R; Malakauskas K; Muley T; Fischer JR; Lahm H
Medicina (Kaunas); 2005; 41(7):566-76. PubMed ID: 16062024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
